nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—PTGER3—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0214	0.0222	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.0144	0.0149	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0133	0.0138	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0131	0.0135	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.013	0.0134	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.0123	0.0127	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.0119	0.0123	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0114	0.0118	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0112	0.0116	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00998	0.0103	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00978	0.0101	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00977	0.0101	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00976	0.0101	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00971	0.01	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00957	0.0099	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0095	0.00983	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00906	0.00937	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00871	0.009	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00855	0.00884	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00854	0.00883	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00853	0.00882	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00838	0.00866	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00837	0.00865	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0082	0.00848	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00792	0.00819	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00778	0.00804	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00776	0.00803	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00768	0.00795	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00755	0.00781	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00746	0.00772	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00736	0.00762	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00734	0.00759	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00713	0.00738	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00701	0.00725	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00695	0.00719	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00692	0.00716	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00679	0.00702	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00678	0.00701	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00666	0.00689	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00663	0.00686	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00651	0.00673	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00645	0.00667	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00638	0.0066	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00637	0.00659	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00631	0.00652	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00624	0.00646	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00611	0.00632	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00601	0.00621	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00593	0.00613	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00592	0.00613	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00591	0.00611	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00581	0.006	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0058	0.006	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00568	0.00588	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00553	0.00571	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00551	0.00569	CbGpPWpGaD
Bimatoprost—PTGER1—nervous system—attention deficit hyperactivity disorder	0.00549	0.166	CbGeAlD
Bimatoprost—PTGFR—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00549	0.00567	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00539	0.00557	CbGpPWpGaD
Bimatoprost—AKR1C3—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00538	0.00556	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00537	0.00555	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00533	0.00552	CbGpPWpGaD
Bimatoprost—PTGER1—central nervous system—attention deficit hyperactivity disorder	0.00528	0.16	CbGeAlD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00524	0.00542	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00522	0.0054	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00518	0.00535	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00517	0.00534	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00513	0.00531	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00507	0.00525	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00507	0.00524	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00498	0.00515	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00497	0.00514	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00492	0.00509	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00488	0.00504	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00482	0.00499	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00482	0.00498	CbGpPWpGaD
Bimatoprost—PTGER3—nervous system—attention deficit hyperactivity disorder	0.00481	0.146	CbGeAlD
Bimatoprost—PTGER3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0048	0.00497	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00472	0.00488	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00472	0.00488	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00465	0.00481	CbGpPWpGaD
Bimatoprost—PTGER3—central nervous system—attention deficit hyperactivity disorder	0.00463	0.14	CbGeAlD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00462	0.00478	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00457	0.00473	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00457	0.00473	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00452	0.00467	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00452	0.00467	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00449	0.00464	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00447	0.00463	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00447	0.00462	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00444	0.00459	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00442	0.00457	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0044	0.00455	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00438	0.00453	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00437	0.00452	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00434	0.00449	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00433	0.00448	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00428	0.00442	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00421	0.00435	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00413	0.00427	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00404	0.00418	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00394	0.00407	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00391	0.00404	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00387	0.004	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00386	0.004	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00383	0.00396	CbGpPWpGaD
Bimatoprost—AKR1C3—midbrain—attention deficit hyperactivity disorder	0.0038	0.115	CbGeAlD
Bimatoprost—PTGER1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00378	0.00391	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00368	0.0038	CbGpPWpGaD
Bimatoprost—PTGER3—brain—attention deficit hyperactivity disorder	0.00368	0.111	CbGeAlD
Bimatoprost—PTGFR—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0036	0.00373	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0036	0.00372	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00359	0.00372	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00353	0.00365	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00352	0.00364	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00348	0.0036	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00342	0.00354	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00341	0.00352	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00338	0.00349	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00338	0.00349	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00335	0.00346	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00334	0.00346	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00334	0.00346	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00331	0.00342	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00331	0.00342	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00327	0.00339	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00327	0.00338	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0032	0.00331	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00315	0.00325	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STUB1—attention deficit hyperactivity disorder	0.0031	0.0032	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00308	0.00319	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00307	0.00318	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00303	0.00314	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00295	0.00305	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00294	0.00304	CbGpPWpGaD
Bimatoprost—AKR1C3—cerebellum—attention deficit hyperactivity disorder	0.00294	0.0891	CbGeAlD
Bimatoprost—PTGER3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00292	0.00302	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00289	0.00299	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00288	0.00298	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00283	0.00293	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00278	0.00287	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00272	0.00281	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00265	0.00274	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00264	0.00273	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00263	0.00272	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00259	0.00267	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00258	0.00267	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00255	0.00264	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00254	0.00262	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0025	0.00258	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00247	0.00255	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00245	0.00253	CbGpPWpGaD
Bimatoprost—AKR1C3—brain—attention deficit hyperactivity disorder	0.00239	0.0723	CbGeAlD
Bimatoprost—PTGER3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00239	0.00247	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00238	0.00246	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00235	0.00243	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00232	0.0024	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0023	0.00238	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00227	0.00235	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00225	0.00233	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00223	0.00231	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00222	0.0023	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0022	0.00228	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00218	0.00226	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00217	0.00224	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00216	0.00223	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00216	0.00223	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00214	0.00221	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00203	0.0021	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00199	0.00206	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00198	0.00205	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00197	0.00204	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00197	0.00203	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00194	0.00201	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00193	0.002	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00193	0.002	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00193	0.002	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00192	0.00199	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00191	0.00197	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0019	0.00196	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00189	0.00196	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00189	0.00196	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00187	0.00193	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00186	0.00193	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00186	0.00192	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00184	0.00191	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00183	0.00189	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0018	0.00187	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00179	0.00185	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00179	0.00185	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00179	0.00185	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00178	0.00184	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00176	0.00182	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00175	0.00181	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00174	0.0018	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00173	0.00179	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00172	0.00178	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.0017	0.00175	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00167	0.00172	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00161	0.00167	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00158	0.00163	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00157	0.00162	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00154	0.00159	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00154	0.00159	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00151	0.00157	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00151	0.00156	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SNAP25—attention deficit hyperactivity disorder	0.00147	0.00152	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00146	0.00151	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00141	0.00146	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00141	0.00146	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00139	0.00143	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00137	0.00142	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00134	0.00139	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00131	0.00136	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00128	0.00132	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00127	0.00131	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00125	0.00129	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00123	0.00127	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00122	0.00126	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00117	0.00121	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00117	0.00121	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00115	0.00119	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00113	0.00117	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00111	0.00114	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00111	0.00114	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00109	0.00113	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00107	0.0011	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00105	0.00109	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00104	0.00107	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00103	0.00107	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00103	0.00106	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00102	0.00106	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00101	0.00105	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.001	0.00104	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000996	0.00103	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000979	0.00101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000967	0.001	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000954	0.000986	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000934	0.000966	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000932	0.000964	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000926	0.000957	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000901	0.000932	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000898	0.000928	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000893	0.000924	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000668	0.000691	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000654	0.000676	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000631	0.000652	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EP300—attention deficit hyperactivity disorder	0.000477	0.000494	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000473	0.00049	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—EP300—attention deficit hyperactivity disorder	0.0004	0.000413	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000354	0.000366	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000346	0.000358	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000334	0.000346	CbGpPWpGaD
